Jarčušková D., Tkáč I., Hlaváčová N., Yaluri A.S., Kozárová M., Habalová V., Klimčáková L., Židzik J., Javorský M., Bednářová A.* (2024). Serotonin transporter 5-HTTLPR polymorphism and escitalopram treatment response in patients with major depressive disorder. BMC Psychiatry. 24(1):690.

*korešp.aut.

Bednářová A., Habalová V., Tkáč I. (2023). BDNF rs962369 is associated with major depressive disorder. Biomedicines, 11(8), 2243.

Bednarova A., Habalova V., Krivosova M., Marcatili M., Tkac I. (2023). Association study of BDNF, SLC6A4, and FTO genetic variants with schizophrenia spectrum disorders. Journal of Personalized Medicine, 13(4), 658.

Bednarova A., Habalova V., Iannaccone S.F., Tkac .I, Jarcuskova D., Krivosova M., Marcatili M., Hlavacova N. ( 2023). Association of HTTLPR, BDNF, and FTO Genetic Variants with Completed Suicide in Slovakia. J Pers Med. Mar 10;13(3):501.

Jarcuskova D., Pallayova M., Carnakovic S., Frajka M., Fidmik J., Bednarova A. (2024). Clinical characteristics of adults with alcohol dependence syndrome comorbid with antisocial personality disorder: a cross-sectional study. Frontiers in Psychiatry, 15, 1397009.

Bednarova A.,Čižmáriková M., Habalová V., Jarčušková D. (2021). Evaluation of 5-HTTLPR (insertion/deletion) and BDNF (rs6265) genetic variations in the Slovakian individuals suffering from affective disorders. General physiology and biophysics. 40, 5, 365-376.

Kiskova T., Bednarova A. (2025) Special Issue "Depression: From Molecular Basis to Therapy". Int J Mol Sci. 18;26(8):3844.

Farkasova Iannaccone S.,* Bednarova A.,* Sopkova D. (2022).Correlation between psychotropic treatment associated with QT prolongation and COVID-19-related myocarditis in a patient with schizophrenia, Psychiatria Danubina, 34, 1, 181-183.

* These authors contributed equally to this work

Bednarova A, Sekula J, Sopkova D, Jarcuska P. 2022. Evaluation of Neuropsychiatric Complications in Hospitalized COVID-19 Patients. Psychiatr Danub. 34(4):752-757

Monitoring the relationship of selected gene variants and proteomic markers in patients with mental disorders as a contribution to their personalized treatment 2019/29-UPJŠ-1- DepDemGen

Scientific grant 2/2020, Slovak Psychiatric Association: Monitoring the relationship of polymorphisms of some candidate genes (5-HTTLPR, BDNF rs 6265, BDNF rs 962369, FTO) and their interconnection with depressive disorder

Monitoring the occurrence of psychiatric symptoms requiring psychiatric intervention in hopspitalized patients with COVID-19, brand of the Department of Biomedical Research and Clinical Trials: 177/2021 / OdBVaKS, biomedical research project UNLP - author and responsible project leader

PSYCHGEN - Monitoring the relationship of polymorphisms of some candidate genes predetermining suicidal behavior in the Slovak population - research project, brand 149/2018 / OVaV (department for research and development)

Psychooncology as a new complex way to integrate psychiatric diagnostic into oncologic care),  vvgs-2021-1872

VEGA 1/0702/25: Monitoring the relationship between selected gene variants, proteomic, endocrine, and retinal markers in patients with depressive disorder with the aim of improving the quality of personalized treatment. - Project leader